The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells

JUSTO PASTOR CASTAÑO FUENTESANTONIO JESÚS MARTÍNEZ FUENTESMANUEL DAVID GAHETE ORTIZMARÍA DEL MAR MALAGÓN POYATORAUL MIGUEL LUQUE HUERTASFRANCISCO GRACIA NAVARRO2026-01-292026-01-29201210.1038/onc.2011.3892-s2.0-84859921027https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/23793Cancer ResearchGeneticsMolecular BiologyCancer ResearchGeneticsMolecular BiologyThe new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cellsresearch article